Drugs that contain Bupivacaine Hydrochloride
1. Xaracoll patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| USRE47826 | INNOCOLL PHARMS | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage |
May, 2029
(5 years from now) | |
| US11746141 | INNOCOLL PHARMS | Modified collagen |
Jan, 2033
(9 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product (NP) | Aug 28, 2023 |
Market Authorisation Date: 28 August, 2020
Treatment: A method for inducing a post-surgical analgesia sparing effect by implanting at the surgical site a collagen sponge containing bupivacaine hcl which provides local anesthesia for up to 24 hours follow...
Dosage: IMPLANT;IMPLANTATION
More Information on Dosage
XARACOLL family patents
